Pennsylvania 2025-2026 Regular Session

Pennsylvania Senate Bill SR101

Introduced
5/5/25  

Caption

Recognizing the month of May 2025 as "Asthma and Allergy Awareness Month" in Pennsylvania.

Impact

By designating May as Asthma and Allergy Awareness Month, the resolution aims to foster education and advocacy around asthma and food allergies. This public recognition can encourage communities and healthcare providers to promote awareness programs and support for individuals suffering from these conditions. The bill does not change any laws but seeks to elevate the conversation around health issues that greatly affect a considerable portion of the population, particularly vulnerable groups such as children.

Summary

Senate Resolution 101 recognizes the month of May 2025 as 'Asthma and Allergy Awareness Month' in Pennsylvania. The resolution emphasizes the importance of raising awareness about asthma and allergies, which are significant public health issues affecting millions of individuals across the United States and specifically in Pennsylvania. It highlights the prevalence of asthma, particularly among children, and the substantial economic burden associated with managing the disease, including healthcare costs and hospital visits.

Sentiment

The sentiment surrounding SR101 is largely positive, as it advocates for the health and well-being of citizens affected by asthma and allergies. Supporters see this resolution as a necessary acknowledgment of a public health crisis that requires continuous education and resources. The positive sentiment reflects a collective understanding of the challenges faced by individuals with these chronic conditions and the need for community support to provide better health outcomes.

Contention

Although there are no prominent points of contention highlighted in the discussions regarding SR101, the bill reflects a consensus on the need for awareness rather than introducing any regulatory or legislative conflict. The resolution's focus is on raising awareness rather than imposing new policies or costs, which often invites less opposition compared to bills with direct regulatory implications.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.